TCL Archive ASCO Publishes Two Clinical Guidelines For Treating HER2-Positive Breast Cancer May 30, 2014
TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014